Literature DB >> 17515919

Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance.

Justin I Odegaard1, Roberto R Ricardo-Gonzalez, Matthew H Goforth, Christine R Morel, Vidya Subramanian, Lata Mukundan, Alex Red Eagle, Divya Vats, Frank Brombacher, Anthony W Ferrante, Ajay Chawla.   

Abstract

Obesity and insulin resistance, the cardinal features of metabolic syndrome, are closely associated with a state of low-grade inflammation. In adipose tissue chronic overnutrition leads to macrophage infiltration, resulting in local inflammation that potentiates insulin resistance. For instance, transgenic expression of Mcp1 (also known as chemokine ligand 2, Ccl2) in adipose tissue increases macrophage infiltration, inflammation and insulin resistance. Conversely, disruption of Mcp1 or its receptor Ccr2 impairs migration of macrophages into adipose tissue, thereby lowering adipose tissue inflammation and improving insulin sensitivity. These findings together suggest a correlation between macrophage content in adipose tissue and insulin resistance. However, resident macrophages in tissues display tremendous heterogeneity in their activities and functions, primarily reflecting their local metabolic and immune microenvironment. While Mcp1 directs recruitment of pro-inflammatory classically activated macrophages to sites of tissue damage, resident macrophages, such as those present in the adipose tissue of lean mice, display the alternatively activated phenotype. Despite their higher capacity to repair tissue, the precise role of alternatively activated macrophages in obesity-induced insulin resistance remains unknown. Using mice with macrophage-specific deletion of the peroxisome proliferator activated receptor-gamma (PPARgamma), we show here that PPARgamma is required for maturation of alternatively activated macrophages. Disruption of PPARgamma in myeloid cells impairs alternative macrophage activation, and predisposes these animals to development of diet-induced obesity, insulin resistance, and glucose intolerance. Furthermore, gene expression profiling revealed that downregulation of oxidative phosphorylation gene expression in skeletal muscle and liver leads to decreased insulin sensitivity in these tissues. Together, our findings suggest that resident alternatively activated macrophages have a beneficial role in regulating nutrient homeostasis and suggest that macrophage polarization towards the alternative state might be a useful strategy for treating type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17515919      PMCID: PMC2587297          DOI: 10.1038/nature05894

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  30 in total

1.  Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology.

Authors:  De'Broski R Herbert; Christoph Hölscher; Markus Mohrs; Berenice Arendse; Anita Schwegmann; Magda Radwanska; Mosiuoa Leeto; Richard Kirsch; Pauline Hall; Horst Mossmann; Björn Claussen; Irmgard Förster; Frank Brombacher
Journal:  Immunity       Date:  2004-05       Impact factor: 31.745

Review 2.  PPARs and the complex journey to obesity.

Authors:  Ronald M Evans; Grant D Barish; Yong-Xu Wang
Journal:  Nat Med       Date:  2004-04       Impact factor: 53.440

3.  Impairment of alternative macrophage activation delays cutaneous leishmaniasis in nonhealing BALB/c mice.

Authors:  Christoph Hölscher; Berenice Arendse; Anita Schwegmann; Elmarie Myburgh; Frank Brombacher
Journal:  J Immunol       Date:  2006-01-15       Impact factor: 5.422

Review 4.  Monocyte and macrophage heterogeneity.

Authors:  Siamon Gordon; Philip R Taylor
Journal:  Nat Rev Immunol       Date:  2005-12       Impact factor: 53.106

Review 5.  The many faces of PPARgamma.

Authors:  Michael Lehrke; Mitchell A Lazar
Journal:  Cell       Date:  2005-12-16       Impact factor: 41.582

Review 6.  Metabolic control through the PGC-1 family of transcription coactivators.

Authors:  Jiandie Lin; Christoph Handschin; Bruce M Spiegelman
Journal:  Cell Metab       Date:  2005-06       Impact factor: 27.287

7.  CCR2 modulates inflammatory and metabolic effects of high-fat feeding.

Authors:  Stuart P Weisberg; Deborah Hunter; Reid Huber; Jacob Lemieux; Sarah Slaymaker; Kris Vaddi; Israel Charo; Rudolph L Leibel; Anthony W Ferrante
Journal:  J Clin Invest       Date:  2005-12-08       Impact factor: 14.808

8.  How obesity causes diabetes: not a tall tale.

Authors:  Mitchell A Lazar
Journal:  Science       Date:  2005-01-21       Impact factor: 47.728

9.  Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase.

Authors:  J T Huang; J S Welch; M Ricote; C J Binder; T M Willson; C Kelly; J L Witztum; C D Funk; D Conrad; C K Glass
Journal:  Nature       Date:  1999-07-22       Impact factor: 49.962

Review 10.  Leishmania species: models of intracellular parasitism.

Authors:  J Alexander; A R Satoskar; D G Russell
Journal:  J Cell Sci       Date:  1999-09       Impact factor: 5.285

View more
  920 in total

Review 1.  cJun NH2-terminal kinase 1 (JNK1): roles in metabolic regulation of insulin resistance.

Authors:  Guadalupe Sabio; Roger J Davis
Journal:  Trends Biochem Sci       Date:  2010-05-07       Impact factor: 13.807

Review 2.  Inflammatory links between obesity and metabolic disease.

Authors:  Carey N Lumeng; Alan R Saltiel
Journal:  J Clin Invest       Date:  2011-06-01       Impact factor: 14.808

3.  p16INK4a deficiency promotes IL-4-induced polarization and inhibits proinflammatory signaling in macrophages.

Authors:  Céline Cudejko; Kristiaan Wouters; Lucía Fuentes; Sarah Anissa Hannou; Charlotte Paquet; Kadiombo Bantubungi; Emmanuel Bouchaert; Jonathan Vanhoutte; Sébastien Fleury; Patrick Remy; Anne Tailleux; Giulia Chinetti-Gbaguidi; David Dombrowicz; Bart Staels; Réjane Paumelle
Journal:  Blood       Date:  2011-06-02       Impact factor: 22.113

4.  TGR5 reduces macrophage migration through mTOR-induced C/EBPβ differential translation.

Authors:  Alessia Perino; Thijs Willem Hendrik Pols; Mitsunori Nomura; Sokrates Stein; Roberto Pellicciari; Kristina Schoonjans
Journal:  J Clin Invest       Date:  2014-11-03       Impact factor: 14.808

5.  Aging is associated with an increase in T cells and inflammatory macrophages in visceral adipose tissue.

Authors:  Carey N Lumeng; Jianhua Liu; Lynn Geletka; Colin Delaney; Jennifer Delproposto; Anjali Desai; Kelsie Oatmen; Gabriel Martinez-Santibanez; Annabelle Julius; Sanjay Garg; Raymond L Yung
Journal:  J Immunol       Date:  2011-11-09       Impact factor: 5.422

Review 6.  Innate Lymphoid Cell Immunometabolism.

Authors:  Timothy E O'Sullivan; Joseph C Sun
Journal:  J Mol Biol       Date:  2017-09-01       Impact factor: 5.469

Review 7.  Endothelial PPARγ Is Crucial for Averting Age-Related Vascular Dysfunction by Stalling Oxidative Stress and ROCK.

Authors:  Md Sahab Uddin; Md Tanvir Kabir; Md Jakaria; Abdullah Al Mamun; Kamal Niaz; Md Shah Amran; George E Barreto; Ghulam Md Ashraf
Journal:  Neurotox Res       Date:  2019-05-04       Impact factor: 3.911

8.  Myeloid cell-specific disruption of Period1 and Period2 exacerbates diet-induced inflammation and insulin resistance.

Authors:  Hang Xu; Honggui Li; Shih-Lung Woo; Sam-Moon Kim; Vikram R Shende; Nichole Neuendorff; Xin Guo; Ting Guo; Ting Qi; Ya Pei; Yan Zhao; Xiang Hu; Jiajia Zhao; Lili Chen; Lulu Chen; Jun-Yuan Ji; Robert C Alaniz; David J Earnest; Chaodong Wu
Journal:  J Biol Chem       Date:  2014-04-25       Impact factor: 5.157

9.  Alternatively Activated Macrophages Revisited: New Insights into the Regulation of Immunity, Inflammation and Metabolic Function following Parasite Infection.

Authors:  Jessica C Jang; Meera G Nair
Journal:  Curr Immunol Rev       Date:  2013-08-01

10.  PPARγ-activation increases intestinal M1 macrophages and mitigates formation of serrated adenomas in mutant KRAS mice.

Authors:  Tobias Gutting; Christian A Weber; Philip Weidner; Frank Herweck; Sarah Henn; Teresa Friedrich; Shuiping Yin; Julia Kzhyshkowska; Timo Gaiser; Klaus-Peter Janssen; Wolfgang Reindl; Matthias P A Ebert; Elke Burgermeister
Journal:  Oncoimmunology       Date:  2018-02-01       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.